EnhancedBio USA Inc.: Clinical Trials

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	1	Unknown 1
Phase 2	1	Unknown 1

Follow EnhancedBio USA Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) ZB716, Palbociclib - Estrogen Receptor-Positive, HER2-Negative	Phase 1 / Phase 2	Unknown	EnhancedBio USA Inc.	106	2021-07-26	2022-03-22

Conditions studied

Breast Neoplasms (1)

Interventions

palbociclib (1)

Countries

South Korea (1)  ·  United States (1)